This online assessment takes only 2 minutes. It will help you find the right clinical trials for you.
We ask this to determine which clinical trials you may be eligible for.
If you need to contact us right away?
Call +1 844 627 7246Your personal data is fully confidential and 100% secure
The Ovarian Cancer Quiz introduces the risk factors, screening and diagnosis methods, and symptoms of ovarian cancer. Ovarian cancer begins in the ovary, a female reproductive organ that produces an ovum (egg). Those at risk of developing ovarian cancer include women over the age of 40, family history of cancer, and those who have children late (age 35 or older) or not at all.
If an abnormality is suspected, a physician will perform the following screening tests for ovarian cancer:
Many symptoms caused by ovarian cancer can also be signs of other diseases and illnesses, so it is important to contact your physician right away once any symptoms are experienced. The most common symptoms experienced in patients with ovarian cancer include:
Other symptoms of ovarian cancer that are seen less often include:
The overall five-year survival rate for ovarian cancer patients is an estimated 45%. Depending on the stage and type of tumor, the rate can change drastically. For example, when treated in an early stage before metastasizing, or localized cases, have a survival rate of 92%. Those in advanced stage IV, called “distant”, have a survival rate of 28%. This shows why early detection of cancer and annual screenings for those at risk of ovarian cancer are so important for the treatment to be successful.
Sources:
NCI (https://www.cancer.gov/)
ACS (https://www.cancer.org/)
Almost Done!
Please complete the required fields and we will send results to your email.
You have completed the quiz.
0 out 0 answers are correct
We ask this to determine which clinical trials you may be eligible for.
Samantha Kingsbery Massive Bio Clinical NurseIf you need to contact us right away?
Call +1 844 627 7246Your personal data is fully confidential and 100% secure